Skip to content

MEDSAM: what changed

Two fiscal years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.

What changed

MEDSAM

BE 0863.447.478
NACE 47.730, Retail sale of pharmaceutical products
fiscal year 2024 against 2025filed annual accounts (NBB)
Net result for the year
€44,663
2024 · €71,021-€26,358
Equity
€342,758
2024 · €323,095+€19,663
Cash
€111,876
2024 · €192,815-€80,938
Balance sheet total
€439,586
2024 · €465,395-€25,809

Largest movements

2024 to 2025
Assets
  • Cash -€80,938

    down €80,938 (-42.0%), from €192,815 to €111,876

    mainly Receivables within one year (-€49,795) and Contributions, distributions and other (-€25,000)

  • Receivables within one year +€49,795

    up €49,795 (+38.5%), from €129,344 to €179,139

    of which Other amounts receivable: +€63,591

  • Stocks and contracts +€5,359

    up €5,359 (+3.8%), from €141,668 to €147,026

Equity and liabilities
  • Reserves +€19,663

    up €19,663 (+6.5%), from €304,495 to €324,158

  • Trade debts -€18,223

    down €18,223 (-20.5%), from €88,732 to €70,510

  • Other debts -€15,550

    down €15,550 (-37.9%), from €41,036 to €25,486

  • Tax, wage and social debts -€7,426

    down €7,426 (-89.9%), from €8,258 to €831

    of which Remuneration and social security: -€7,270

Income statement
  • Gross operating margin -€20,489

    down €20,489 (-10.0%), from €204,286 to €183,797

  • Staff costs +€11,917

    up €11,917 (+11.2%), from €106,163 to €118,080

  • Other operating charges -€6,003

    down €6,003 (-52.6%), from €11,413 to €5,410

  • Taxes -€3,770

    down €3,770 (-33.3%), from €11,339 to €7,568

  • Financial charges +€3,507

    up €3,507 (+69.5%), from €5,044 to €8,551

From the 2024 result to the 2025 result

effect on the result

Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.

Result 2024 €71,021
Gross operating margin -€20,489
Staff costs -€11,917
Depreciation +€130
Other operating charges +€6,003
Financial income -€348
Financial charges -€3,507
Taxes +€3,770
Result 2025 €44,663

Cash bridge derived

cash 2024 to 2025

Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.

From operations -€51,664
Investment €0
Financing -€29,274
Cash 2024 €192,815
Net result for the year +€44,663
Depreciation +€547
Stocks and contracts -€5,359
Receivables within one year -€49,795
Deferred charges and accrued income -€522
Trade debts -€18,223
Tax, wage and social debts -€7,426
Other debts -€15,550
Current portion of long-term debt -€4,274
Contributions, distributions and other -€25,000
Cash 2025 €111,876
Every line side by side 40 lines
Line Code 2024 2025 Change %
Total assets 20/58 €465,395 €439,586 -€25,809 -5.5%
Fixed assets 21/28 €1,217 €670 -€547 -45.0%
Tangible fixed assets 22/27 €1,217 €670 -€547 -45.0%
Plant, machinery and equipment 23 €548 €415 -€133 -24.3%
Furniture and vehicles 24 €669 €255 -€414 -61.9%
Current assets 29/58 €464,178 €438,916 -€25,262 -5.4%
Stocks and contracts in progress 3 €141,668 €147,026 +€5,359 +3.8%
Stocks 30/36 €141,668 €147,026 +€5,359 +3.8%
Amounts receivable within one year 40/41 €129,344 €179,139 +€49,795 +38.5%
Trade receivables 40 €110,325 €96,529 -€13,796 -12.5%
Other amounts receivable 41 €19,019 €82,610 +€63,591 +334.4%
Cash at bank and in hand 54/58 €192,815 €111,876 -€80,938 -42.0%
Deferred charges and accrued income 490/1 €352 €874 +€522 +148.5%
Total equity and liabilities 10/49 €465,395 €439,586 -€25,809 -5.5%
Equity 10/15 €323,095 €342,758 +€19,663 +6.1%
Contributions 10/11 €18,600 €18,600 = 0.0%
Reserves 13 €304,495 €324,158 +€19,663 +6.5%
Distributable reserves 133 €304,495 €324,158 +€19,663 +6.5%
Amounts payable 17/49 €142,300 €96,827 -€45,473 -32.0%
Amounts payable within one year 42/48 €142,300 €96,827 -€45,473 -32.0%
Current portion of amounts payable after more than one year 42 €4,274 - -€4,274
Trade debts 44 €88,732 €70,510 -€18,223 -20.5%
Suppliers 440/4 €88,732 €70,510 -€18,223 -20.5%
Taxes, remuneration and social security 45 €8,258 €831 -€7,426 -89.9%
Taxes 450/3 €156 - -€156
Remuneration and social security 454/9 €8,102 €831 -€7,270 -89.7%
Other amounts payable 47/48 €41,036 €25,486 -€15,550 -37.9%
Remuneration, social security and pensions 62 €106,163 €118,080 +€11,917 +11.2%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €678 €547 -€130 -19.2%
Other operating charges 640/8 €11,413 €5,410 -€6,003 -52.6%
Gross operating margin 9900 €204,286 €183,797 -€20,489 -10.0%
Operating profit (loss) 9901 €86,033 €59,759 -€26,273 -30.5%
Financial income 75/76B €1,371 €1,023 -€348 -25.4%
Recurring financial income 75 €1,371 €1,023 -€348 -25.4%
Financial charges 65/66B €5,044 €8,551 +€3,507 +69.5%
Recurring financial charges 65 €5,044 €8,551 +€3,507 +69.5%
Profit (loss) for the period before taxes 9903 €82,360 €52,232 -€30,128 -36.6%
Income taxes 67/77 €11,339 €7,568 -€3,770 -33.3%
Profit (loss) for the period 9904 €71,021 €44,663 -€26,358 -37.1%
Profit (loss) for the period to be appropriated 9905 €71,021 €44,663 -€26,358 -37.1%

Source: filed annual accounts (NBB), fiscal years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 7 October 2026 via checked.be.